Lapasanda, Mark Jesser C.

HRN: 04-36-88  Sex: Male

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
06/28/2026
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
06/28/2026
07/05/2026
IV
500
Q6
Intestinal Amoebiasis
Pending Pharmacy Acceptance 

 Indication:  Empiric    Type of Infection:  Intra-abdominal    Compliance to guidelines: